Floatz logo

20 assets in Plasma Cell Neoplasm

Therapeutic assets addressing Plasma Cell Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Dexasone
Plasma Cell Neoplasm
Hellenic Society of HematologyP3BBB (72)
Lenalidomide
Plasma Cell Neoplasm
Hellenic Society of HematologyP3BBB (72)
Cyclophosphamide
Plasma Cell Neoplasm
Affiliated Hospital to Academy of Military Medical SciencesP3BB (70)
Fludarabine
Plasma Cell Neoplasm
Affiliated Hospital to Academy of Military Medical SciencesP3BB (69)
Nivestim
Plasma Cell Neoplasm
Hellenic Society of HematologyP3BB (68)
Tacrolimus
Plasma Cell Neoplasm
Dartmouth-Hitchcock Medical CenterP3BB (65)
Pomalidomide
Plasma Cell Neoplasm
Hellenic Society of HematologyP2B (60)
Bortezomib
Plasma Cell Neoplasm
Hellenic Society of HematologyP2CCC (53)
Isatuximab
Plasma Cell Neoplasm
Hellenic Society of HematologyP2CCC (53)
Ranitidine
Plasma Cell Neoplasm
Hellenic Society of HematologyP2CCC (53)
Diphenhydramine
Plasma Cell Neoplasm
Hellenic Society of HematologyP2CCC (51)
Bcma Car-T Cells
Plasma Cell Neoplasm
Chongqing Precision Biotech Co., LtdP1/2CCC (48)
Bcma Targeted Prime Car-T Cells
Plasma Cell Neoplasm
Chongqing Precision Biotech Co., LtdP1/2CCC (48)
Belantamab Mafodotin
Plasma Cell Neoplasm
Hellenic Society of HematologyP1/2CCC (48)
Daratumumab
Plasma Cell Neoplasm
Hellenic Society of HematologyP1/2CC (47)
Nirogacestat
Plasma Cell Neoplasm
Hellenic Society of HematologyP1/2CC (45)
Oricar-017
Plasma Cell Neoplasm
OriCell Therapeutics Co., Ltd.P1CC (43)
car19bcma-t cells
Plasma Cell Neoplasm
Affiliated Hospital to Academy of Military Medical SciencesEarly P1C (39)
Hdp-101
Plasma Cell Neoplasm
Heidelberg Pharma AGP1/2NR ()
lm-305
Plasma Cell Neoplasm
LaNova Medicines LimitedP1/2NR ()